ICD-10 Code B46.3 | Cutaneous mucormycosis Symptoms, Diagnosis, Billing

Cutaneous mucormycosis is a severe fungal infection caused by molds of the Mucorales order, primarily affecting the skin. It is clinically significant due to its rapid progression and potential for serious complications, particularly in immunocompromised patients. Accurate coding with ICD-10 Code B46.3 is essential for proper diagnosis, documentation, medical billing, and public health reporting.

What is ICD-10 Code B46.3 for Cutaneous mucormycosis?

ICD-10 Code B46.3 represents Cutaneous mucormycosis, a fungal infection characterized by necrotizing skin lesions. This code is used when documenting cases of cutaneous mucormycosis, particularly in patients with underlying conditions such as diabetes or immunosuppression. It is crucial for accurate clinical documentation and billing to ensure appropriate treatment and resource allocation.

ICD-10 Code B46.3 – Clinical Definition and Explanation of Cutaneous mucormycosis

Cutaneous mucormycosis is primarily caused by fungi in the Mucorales order, often entering through breaks in the skin. The condition can progress rapidly, leading to extensive tissue necrosis and systemic involvement, necessitating urgent medical intervention.

Key Clinical Features:

• Rapidly progressing necrotic skin lesions
• Commonly associated with immunocompromised states
• Potential for systemic spread if untreated
• May present with pain, swelling, and erythema

ICD-10 Code B46.3 for Cutaneous mucormycosis – SOAP Notes & Clinical Use

ICD-10 Code B46.3 is utilized in SOAP notes to document the presence of cutaneous mucormycosis, aiding in the assessment of symptoms, clinical findings, and treatment plans. This code is relevant in both acute and chronic care settings, ensuring comprehensive patient management.

What Does ICD-10 Code B46.3 for Cutaneous mucormycosis Mean in SOAP Notes?

In SOAP notes, ICD-10 Code B46.3 connects subjective patient-reported symptoms and objective clinical findings to a formal diagnosis of cutaneous mucormycosis. This ensures continuity of care, supports accurate billing, and meets EHR documentation standards.

Treatment Options for ICD-10 Code B46.3 – Cutaneous mucormycosis

Cutaneous mucormycosis requires prompt medical attention and often hospitalization due to its aggressive nature. Treatment typically involves antifungal therapy and supportive care.

Antibiotic Therapy:

• Amphotericin B (first-line, duration varies based on response)
• Posaconazole (alternative, duration varies)
• Isavuconazole (alternative, duration varies)

Supportive Care:

• Wound care and debridement of necrotic tissue
• Management of underlying conditions (e.g., diabetes)
• Pain management and nutritional support

Infection Control:

• Implement standard precautions to prevent spread
• Educate staff on handling infected materials
• Monitor for outbreaks in immunocompromised populations

How to Document Symptoms of Cutaneous mucormycosis (ICD-10 B46.3) in SOAP Notes

Subjective:

• Patient reports painful, swollen lesions on the skin
• History of diabetes and recent immunosuppressive therapy
• Complaints of fever and malaise

Objective:

• Erythematous, necrotic lesions observed on examination
• Fever of 101°F noted
• Laboratory tests show elevated white blood cell count

Secure, compliant, and built for trust

HIPAA-compliant and designed with privacy in mind, your patient’s data is protected. Focus on care while we safeguard your information.

Learn more

SOAP Note Guidelines for Diagnosing Cutaneous mucormycosis (ICD-10 Code B46.3)

Assessment:

• Diagnosis: Cutaneous mucormycosis, severe
• ICD-10 Code: B46.3
• Contributing factors: Diabetes, immunosuppression

Plan:

• Initiate amphotericin B therapy
• Consult infectious disease specialist
• Schedule follow-up in 1 week to assess treatment response

Treatment & Plan Section for ICD-10 Code B46.3 – Cutaneous mucormycosis

• Administer antifungal therapy as per guidelines
• Educate patient on signs of worsening infection
• Monitor blood glucose levels closely
• Arrange for surgical consultation for debridement if necessary

Using ICD-10 Code B46.3 for Cutaneous mucormycosis in Billing & SOAP Note Compliance

• Ensure accurate documentation of symptoms and clinical findings
• Use B46.3 in conjunction with relevant codes for underlying conditions
• Align treatment plans with clinical guidelines to support billing
• Include detailed notes on patient education and follow-up plans

Related ICD-10 Codes Often Used with Cutaneous mucormycosis

• B46.0 – Rhinocerebral mucormycosis
• B46.1 – Pulmonary mucormycosis
• B46.2 – Gastrointestinal mucormycosis
• B46.9 – Mucormycosis, unspecified

ICD-10 Code B46.3 in Medical Billing and Insurance for Cutaneous mucormycosis

ICD-10 Code B46.3 is critical in billing for hospital, ER, or infectious disease care related to cutaneous mucormycosis.

Billing Notes:

• Document all relevant clinical findings to support the diagnosis
• Use B46.3 in the context of patient history and treatment plans
• Ensure compliance with payer requirements for documentation

Common CPT Pairings: